Today, the New York Times released a groundbreaking story on the government’s secret spying program on a group of whistleblowers employed by the Food and Drug Administration (FDA).
Stephen M. Kohn, the Executive Director of the National Whistleblower Center and the lead attorney for the FDA whistleblowers, issued the following statement:
We hope that the revelations in today’s New York Times will mark a turning point in the battle to stop the retaliatory surveillance of whistleblowers who risk their careers to report misconduct.
The spying program revealed in today’s New York Times article was illegal. The story demonstrated how government mangers used a covert spying program to interfere with the ability of federal employees to lawfully report significant threats to the public safety to Congress, law enforcement officials and the American people. We hope that these public disclosures will mark the beginning of the end of government spying on employees who report misconduct to the appropriate authorities.
